Partial Seizures

• FDA approval · 2011-07-06
  FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Felbamate submitted by Mylan Pharmaceuticals Inc., updating the approved use of Felbamate un…

• FDA approval · 2011-05-27
  FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

  FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp. under NDA 020789.

• FDA approval · 2010-09-29
  FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for zonisamide submitted by Aurobindo Pharma Limited. It indicates regulatory approval for chang…

• FDA approval · 2010-02-26
  FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' supplemental application for zonisamide (generic) under ANDA077634. This action approves the sup…

• FDA approval · 2009-06-26
  FDA Approved: OXCARBAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved Sun Pharmaceutical Industries' original ANDA for oxcarbazepine, yielding a generic version of this anticonvulsant.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-04-23
  FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for felbamate (Felbatol) filed by Mylan Pharmaceuticals Inc.

• FDA approval · 2009-04-23
  FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for tiagabine hydrochloride under NDA No. NDA020646, managed by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2008-04-09
  FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Limited)

  The FDA approved Advagen Pharma Limited's original ANDA for oxcarbazepine, a generic anticonvulsant.

• FDA approval · 2007-10-09
  FDA Approved: OXCARBAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' original application for a generic oxcarbazepine product. This marks approval of a generic versi…

• FDA approval · 2006-11-20
  FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

  FDA approved a supplemental application for Zonegran (zonisamide) submitted by Advanz Pharma (US) Corp.

• FDA approval · 2006-05-31
  FDA Approved: ZONISAMIDE — Original Application (Exelan Pharmaceuticals, Inc.)

  The FDA approved Exelan Pharmaceuticals' original (ANDA) application for zonisamide, enabling a generic version of the anticonvulsant for us…